What is the recommended treatment for patients with end-stage renal disease on hemodialysis?
IV alteplase is recommended in patients with end-stage renal disease on hemodialysis and normal aPTT (activated partial thromboplastin time). However, those with elevated aPTT may have elevated risk for hemorrhagic complications (COR I; LOE C-LD).